Homburger advises Credit Suisse on the envisaged merger with Neue Aargauer Bank. The team is led by partners Dieter Gericke (Corporate/M&A - pictured right) and Benjamin Leisinger (Banking and Finance - pictured left).
Tags :Benjamin Leisinger
The team was led by partner Benjamin Leisinger (pictured) and included partners René Bösch and Stefan Kramer as well as associates David Borer and Pierina Janett-Seiler (all capital markets).
Credit Suisse receives approval for the first-ever prospectus complying with the New Swiss Prospectus Regime
Homburger advised Credit Suisse with respect to all aspects of Swiss law. The team was led by partner René Bösch (capital markets - pictured) and included partners Benjamin Leisinger
Credit Suisse Group launched and completed the issuance of GBP 750 m 2.250 per cent. fixed rate reset senior callable Notes due 2022 under its newly established Medium Term Note (MTN) Programme
Homburger advised ADCT Therapeutics on this transaction. The team was led by partner Dieter Gericke
Credit Suisse launched abd completed the issuance of EUR 1.5 bn aggregate principal amount of floating rate senior notes due May 2022, and EUR 500 m aggregate principal amount of 0.450% fixed rate senior notes due May 202
ADC Therapeutics listed its shares on the New York Stock Exchange (ticker symbol ADCT). It is the first Swiss company to go public in 2020.
Quintet Private Bank announced that it completed the acquisition of Bank am Bellevue (now rebranded to Quintet Private Bank (Switzerland)), the wealth management business of the independent Swiss financial boutique Bellevue Group.
On April 6, 2020, Credit Suisse launched, and on April 9, 2020 successfully completed, its registered offering of Usd 1.5 bn aggregate principal amount of 2.800% fixed rate senior notes due 2022, and Usd 1.5 bn aggregate principal amount of 2.950% fixed rate senior
